Literature DB >> 9207871

[Preventive analgesic effect of intraoperative administration of ibuprofen-arginine on postmastectomy pain syndrome].

F Lakdja1, F Dixmérias, E Bussières, J M Fonrouge, A Lobéra.   

Abstract

The efficacy of preemptive analgesia on postoperative pain is discussed. From experimental neurophysiological data, the present policy of preventive analgesia aims at precluding modifications of the nervous system secondary to a nervous lesion and the appearance of chronic pain, particularly of the neurogenic kind. The post-mastectomy pain syndrome (PMPS) falls within the realm of neurogenic pain and is still poorly understood and underestimated. This study evaluated the preemptive effect of a perioperative administration of an oral non steroid anti-inflammatory, the ibuprofen-arginine, on PMPS. Thirty patients scheduled for partial or total mastectomy with axillary dissection were prospectively and randomly assigned to 2 groups. The ibuprofen-arginine group (group I) (n = 15), received an oral administration of 400 mg of ibuprofen-arginine, 90 min before surgery, 2 h after surgery and then every 8 h in the first 32 postoperative hours. The control group (group C) received in doubled blind a placebo at the same time. At 6 months, we looked after pain or dysesthesia. We confirmed the diagnosis of PMPS in presence of association of diagnosis criterias. Fourteen patients in each group have been included. Eighty-six percent of the patients (13 patients in group I and 11 patients in group C) presented at 6 months dysesthesia of the upper member ipsilateral to the mastectomy and/or the operated breast, appearing either immediately or after a laps of time. Nine patients (group I) and 6 patients (group C) had PMPS. Postoperative radiotherapy and lymphoedema were statistically associated with PMPS (p = 0.019 and p = 0.011). The perioperative preventive administration of a non-steroid anti-inflammatory drug reduces neither the incidence of pain in the first post-operative months, nor the appearance of PMPS at 6 months. These results suggest that others factors than the nervous lesion may play a role in the occurrence of PMPS, as radiotherapy, lymphoedema, but also psychosocials factors.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207871

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  11 in total

Review 1.  Oral morphine for cancer pain.

Authors:  Philip J Wiffen; Bee Wee; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2016-04-22

Review 2.  Preventive analgesia and novel strategies for the prevention of chronic post-surgical pain.

Authors:  Hance Clarke; Michael Poon; Aliza Weinrib; Rita Katznelson; Kirsten Wentlandt; Joel Katz
Journal:  Drugs       Date:  2015-03       Impact factor: 9.546

Review 3.  Pharmacotherapy for the prevention of chronic pain after surgery in adults.

Authors:  Luis Enrique Chaparro; Shane A Smith; R Andrew Moore; Philip J Wiffen; Ian Gilron
Journal:  Cochrane Database Syst Rev       Date:  2013-07-24

Review 4.  Perioperative systemic nonsteroidal anti-inflammatory drugs (NSAIDs) in women undergoing breast surgery.

Authors:  Kevin M Klifto; Ala Elhelali; Rachael M Payne; Carisa M Cooney; Michele A Manahan; Gedge D Rosson
Journal:  Cochrane Database Syst Rev       Date:  2021-11-09

Review 5.  Perioperative interventions to reduce chronic postsurgical pain.

Authors:  Ian Carroll; Jennifer Hah; Sean Mackey; Einar Ottestad; Jiang Ti Kong; Sam Lahidji; Vivianne Tawfik; Jarred Younger; Catherine Curtin
Journal:  J Reconstr Microsurg       Date:  2013-03-05       Impact factor: 2.873

6.  A randomized, double-blind, placebo-controlled trial of preemptive analgesia with bupivacaine in patients undergoing mastectomy for carcinoma of the breast.

Authors:  Jacek Zielinski; Radoslaw Jaworski; Irmina Smietanska; Ninela Irga; Maria Wujtewicz; Janusz Jaskiewicz
Journal:  Med Sci Monit       Date:  2011-10

Review 7.  Chronic pain after surgery: what can we do to prevent it.

Authors:  Scott S Reuben
Journal:  Curr Pain Headache Rep       Date:  2007-02

Review 8.  Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations.

Authors:  Jennifer S Gewandter; Robert H Dworkin; Dennis C Turk; John T Farrar; Roger B Fillingim; Ian Gilron; John D Markman; Anne Louise Oaklander; Michael J Polydefkis; Srinivasa N Raja; James P Robinson; Clifford J Woolf; Dan Ziegler; Michael A Ashburn; Laurie B Burke; Penney Cowan; Steven Z George; Veeraindar Goli; Ole X Graff; Smriti Iyengar; Gary W Jay; Joel Katz; Henrik Kehlet; Rachel A Kitt; Ernest A Kopecky; Richard Malamut; Michael P McDermott; Pamela Palmer; Bob A Rappaport; Christine Rauschkolb; Ilona Steigerwald; Jeffrey Tobias; Gary A Walco
Journal:  Pain       Date:  2015-07       Impact factor: 7.926

9.  Hyperalgesia and Persistent Pain after Breast Cancer Surgery: A Prospective Randomized Controlled Trial with Perioperative COX-2 Inhibition.

Authors:  Noud van Helmond; Monique A Steegers; Gertie P Filippini-de Moor; Kris C Vissers; Oliver H Wilder-Smith
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

Review 10.  Poorly controlled postoperative pain: prevalence, consequences, and prevention.

Authors:  Tong J Gan
Journal:  J Pain Res       Date:  2017-09-25       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.